← FDA DRUG APPROVALS

FDA ANDA · ANDA213127

CELECOXIB

Sponsor: STRIDES PHARMA

APPLICATION
ANDA213127
TYPE
ANDA
ORIGINAL APPROVAL
2025-04-29
LATEST ACTION
2025-04-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CELECOXIBDiscontinued
CELECOXIB 400MG · CAPSULE · ORAL
CELECOXIBDiscontinued
CELECOXIB 100MG · CAPSULE · ORAL
CELECOXIBDiscontinued
CELECOXIB 200MG · CAPSULE · ORAL

Approval history

2025-04-29UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →